# Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

> Federal funding opportunity · **POSTED** · National Institutes of Health · close: **01/07/2027**

## Key facts

- **Opportunity ID:** 357202
- **Opportunity number:** PAR-25-069
- **Agency:** National Institutes of Health
- **Status:** posted
- **Document type:** synopsis
- **Open date:** 11/18/2024
- **Close date:** 01/07/2027
- **CFDA codes:** 93.393

## Primary source

Grants.gov opportunity detail: https://www.grants.gov/search-results-detail/357202

## Citation

> US Grants.gov, funding opportunity 357202 (PAR-25-069). Retrieved via AI Analytics 2026-05-17 from https://api.ai-analytics.org/opportunity/357202. Licensed CC0.

---

*[Grants.gov dataset](/datasets/grants-gov) · CC0 1.0*